Jane Street’s PDS Biotechnology PDSB Stock Holding History

Jane Street’s Portfolio PDSB Stock Details PDSB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$246K	Buy	+279,664	New	+$297K	﹤0.01%	9635
2025 Q4	–	Sell	-36,581	Closed	-$36.9K	–	12060
2025 Q3	$36.9K	Sell	36,581 -32,670	-47%	-$38.4K	﹤0.01%	10418
2025 Q2	$92.1K	Buy	+69,251	New	+$94K	﹤0.01%	8987
2025 Q1	–	Sell	-35,644	Closed	-$58.1K	–	10319
2024 Q4	$58.1K	Buy	+35,644	New	+$94.3K	﹤0.01%	8930
2024 Q3	–	Sell	-114,032	Closed	-$334K	–	10193
2024 Q2	$334K	Buy	114,032 +38,753	+51%	+$124K	﹤0.01%	7639
2024 Q1	$298K	Buy	75,279 +54,917	+270%	+$283K	﹤0.01%	7578
2023 Q4	$101K	Buy	+20,362	New	+$101K	﹤0.01%	8573
2023 Q3	–	Sell	-39,422	Closed	-$198K	–	9183
2023 Q2	$198K	Sell	39,422 -84,514	-68%	-$553K	﹤0.01%	7682
2023 Q1	$762K	Buy	123,936 +92,807	+298%	+$759K	﹤0.01%	5545
2022 Q4	$411K	Buy	31,129 +7,967	+34%	+$56.2K	﹤0.01%	6478
2022 Q3	$69K	Buy	+23,162	New	+$98.3K	﹤0.01%	8807
2022 Q1	–	Sell	-19,329	Closed	-$157K	–	10854
2021 Q4	$157K	Buy	19,329 +2,590	+15%	+$27.9K	﹤0.01%	8975
2021 Q3	$249K	Buy	+16,739	New	+$209K	﹤0.01%	8517
2018 Q4	–	Sell	-1,024	Closed	-$17K	–	5503
2018 Q3	$17K	Sell	1,024 -2,033	-67%	-$36.5K	﹤0.01%	4977
2018 Q2	$63K	Buy	+3,057	New	+$63.8K	﹤0.01%	4795

Other funds holding PDSB

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

MCM

Militia Capital Management Austin, Texas $3.37B AUM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Jane Street's PDSB Position: Q2 2026 in Review

Jane Street opened a new position in PDS Biotechnology (PDSB) in Q2 2026: 279,664 shares worth $246K. The stake represents ﹤0.01% of the portfolio and ranks #9635 among its holdings. This is a return to the name: Jane Street previously reported a position in PDSB as recently as Q3 2025.

Jane Street first reported a position in PDSB in Q2 2018 and has held it in 15 quarters since. The position peaked at $762K in Q1 2023. 52 funds tracked by Wall St. Rank hold PDSB as of Q2 2026.

Jane Street held 279,664 shares of PDS Biotechnology worth $246K as of Q2 2026.
PDS Biotechnology was a new Jane Street position in Q2 2026.
PDS Biotechnology made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #9635 holding.
Jane Street first reported a position in PDS Biotechnology in Q2 2018 and has held it in 15 quarters since.
Jane Street's PDS Biotechnology position peaked at $762K in Q1 2023.
52 funds tracked by Wall St. Rank held PDS Biotechnology as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.